Perbedaan Organon Pharma Indonesia Tbk. dan TBS Energi Utama Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan TBS Energi Utama Tbk. diperdagangkan di Rp550 (kapitalisasi pasar 4,66 T, volume 24 jam 12,37 jt). Perbedaan utamanya: TBS Energi Utama Tbk. jauh lebih besar — sekitar 44,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TOBA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 4,66 T |
Volume | — | 12,37 jt |
Lot | — | 123,7 rb |
Perputaran | — | 6,73 M |
Harga Rata-rata | — | 544,18 |
Nilai Transaksi | — | 6,73 M |
Harga Ekuilibrium Indikatif | — | 550 |
Volume Ekuilibrium Indikatif | — | 2,35 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Toba Bara Sejahtra (The Company) Tbk was established in Indonesia as PT Buana Persada Gemilang based on the Deed No. 1 dated August 3, 2007 made before Tintin Surtini, S.H., M.Kn, as asubstitute notary of Surjadi, S.H., Jakarta.
Selengkapnya di halaman TOBA →